[Federal Register Volume 88, Number 87 (Friday, May 5, 2023)]
[Notices]
[Pages 29131-29132]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09547]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Advisory Council for the Elimination of Tuberculosis (ACET). This 
meeting is open to the public, limited only by the number of audio and 
web conference lines (1,000 audio and web conference lines are 
available). Time will be available for public.

DATES: The meeting will be held on June 20, 2023, from 9:30 a.m. to 
5:30 p.m., EDT, and June 21, 2023, from 9 a.m. to 12 p.m., EDT.
    Written comments must be submitted by June 13, 2023. Registration 
to make oral comments must also be submitted by June 13, 2023.

ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID: 
160 044 5648, and the Passcode is 54633168. The web conference access 
is https://cdc.zoomgov.com/j/1610445648?pwd=dExvWksyUHRBMHBIcGg2V3VzSGQ1UT09, and the Passcode is 
1@yr$G#H. The number of available audio and web conference lines is 
1,000.

FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management 
Lead, Office of Policy, Planning, and Partnerships, National Center for 
HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-3423; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Council for the Elimination of Tuberculosis 
(ACET) advises and makes recommendations regarding the elimination of 
tuberculosis (TB) to the Secretary of Health and Human Services, the 
Assistant Secretary for Health, and the Director, Centers for Disease 
Control and Prevention (CDC). Specifically, the Council makes 
recommendations regarding policies, strategies, objectives, and 
priorities; addresses the development and application of new 
technologies; provides guidance and review on CDC's Tuberculosis 
Prevention Research portfolio and program priorities; and reviews the 
extent to which progress has been made toward eliminating TB.
    Matters to be Considered: The agenda will include discussions on: 
(1) strengthening TB public health infrastructure through data 
modernization; (2) equitable access to TB diagnostics; (3) revisions to 
the Tuberculosis Technical Instructions for Panel Physicians and Civil 
Surgeons; and (4) provider education and access to TB diagnostics. 
Agenda items are subject to change as priorities dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing [email protected] with subject line ``ACET 
June 2023 Public Comment Registration'' by June 13, 2023.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
[email protected] with subject line ``ACET June 2023 Public Comment 
Registration'' by June 13, 2023. The

[[Page 29132]]

public comment period is on June 20, 2023, at 5 p.m., EDT.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-09547 Filed 5-4-23; 8:45 am]
BILLING CODE 4163-18-P